Bank of America’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-164,000
Closed -$31.4M 7500
2019
Q4
$31.4M Buy
164,000
+4,000
+3% +$722K ﹤0.01% 1511
2019
Q3
$26.9M Buy
160,000
+143,700
+882% +$23.4M ﹤0.01% 1579
2019
Q2
$2.73M Sell
16,300
-21,900
-57% -$3.03M ﹤0.01% 3776
2019
Q1
$5.59M Sell
38,200
-85,900
-69% -$12.5M ﹤0.01% 3054
2018
Q4
$16.6M Sell
124,100
-130,000
-51% -$21.3M ﹤0.01% 1827
2018
Q3
$48.4M Buy
254,100
+14,200
+6% +$2.61M 0.01% 1126
2018
Q2
$40M Buy
239,900
+197,700
+468% +$31.7M 0.01% 1252
2018
Q1
$7.1M Sell
42,200
-347,800
-89% -$58.3M ﹤0.01% 2739
2017
Q4
$63.8M Buy
390,000
+160,400
+70% +$28.8M 0.01% 955
2017
Q3
$47.1M Buy
229,600
+97,600
+74% +$22.7M 0.01% 1187
2017
Q2
$32.1M Sell
132,000
-261,700
-66% -$61.5M 0.01% 1339
2017
Q1
$94.1M Sell
393,700
-249,500
-39% -$58.1M 0.02% 707
2016
Q4
$135M Buy
643,200
+467,500
+266% +$96.8M 0.03% 545
2016
Q3
$40.5M Buy
175,700
+8,900
+5% +$2.17M 0.01% 1119
2016
Q2
$38.5M Buy
166,800
+10,300
+7% +$2.37M 0.01% 1147
2016
Q1
$41.9M Sell
156,500
-3,261,000
-95% -$933M 0.01% 1050
2015
Q4
$1.07B Buy
3,417,500
+3,319,400
+3,384% +$988M 0.25% 100
2015
Q3
$26.7M Sell
98,100
-155,700
-61% -$47.8M 0.01% 1393
2015
Q2
$77M Buy
253,800
+8,200
+3% +$2.45M 0.03% 669
2015
Q1
$73.1M Buy
245,600
+209,300
+577% +$59.7M 0.02% 642
2014
Q4
$9.34M Sell
36,300
-85,900
-70% -$21.5M ﹤0.01% 1994
2014
Q3
$29.5M Buy
122,200
+54,900
+82% +$12.3M 0.01% 1143
2014
Q2
$15M Buy
67,300
+31,400
+87% +$6.5M ﹤0.01% 1610
2014
Q1
$7.39M Buy
35,900
+30,700
+590% +$6.08M ﹤0.01% 2033
2013
Q4
$874K Sell
5,200
-1,700
-25% -$266K ﹤0.01% 4202
2013
Q3
$994K Sell
6,900
-47,500
-87% -$6.33M ﹤0.01% 3962
2013
Q2
$6.87M Buy
+54,400
New +$6.16M ﹤0.01% 2019

Other funds holding AGN

Bank of America's AGN Position: Q2 2020 in Review

Bank of America sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 8,432,014 shares — an estimated $1.49B sold.

Bank of America first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.49B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Bank of America reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Bank of America sold 8,432,014 Allergan plc shares in Q2 2020, an estimated $1.49B.
  • Bank of America first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Bank of America's Allergan plc position peaked at $1.49B in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Bank of America's 13F filing for Q2 2020, filed 14 Aug 2020.